Investors in Amicus Therapeutics Inc (Symbol: FOLD) saw new options become available today, for the March 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the FOLD options chain for the …
NASDAQ1mon
I’ll admit, it’s not the most confidence-inspiring headline. Still, with Tapco furniture’s reputation it’s the most positive headline I could write, without risking the accusation of being on their payroll. In many cases, Tapco’s reputation as a ...
Question: Have the stock gains since Election Day been erased by the sell ... A: Anxiety over what happens in the bond market. The risk is two-fold, but both are …
Amicus Therapeutics, Inc. says that the FDA is allowing it to submit a new drug application for migalastat. This is the company’s oral precision medicine to treat Fabry disease. FOLD stock is on the rise after the company said it will …
and driving up stock-target prices from analyst groups. Tapestry TPR, -2.21% , …
I just stumbled upon an incredibly constructive-looking chart within a very lucrative sector. I am not going to beat about the bush, the investment that contains this incredibly constructive stock chart is Amicus Therapeutics, Inc. (NASDAQ: …
Amicus Therapeutics, Inc. FOLD was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues …
There’s a good chance these issues pretty swiftly disappear once Diego Chara is back in the fold, but it hasn’t been a repeat of the tremendous preseason that …
PHOENIX--In a move to form a new company, Insurance Marketing & Management Services is offering members of Group 500--a special membership program with the infrastructure of a large insurance marketing network--an opportunity to …
Amicus Therapeutics, Inc. (NASDAQ:FOLD) stock was flying high today on positive news from the U.S. Food and Drug Administration (FDA). Amicus Therapeutics, Inc. says that the FDA is allowing it to submit a new drug application for …